Cellular Uptake and Transport Mechanism of 6-Mercaptopurine Nanomedicines for Enhanced Oral Bioavailability
Yaru Zou,Wei Gao,Huizhen Jin,Chenmei Mao,Yi Zhang,Xiaoling Wang,Dong Mei,Libo Zhao
DOI: https://doi.org/10.2147/IJN.S394819
IF: 7.033
2023-01-05
International Journal of Nanomedicine
Abstract:Yaru Zou, 1, 2 Wei Gao, 3 Huizhen Jin, 2 Chenmei Mao, 2 Yi Zhang, 1 Xiaoling Wang, 1 Dong Mei, 1 Libo Zhao 1, 4 1 Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China; 2 Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, Jiangsu, 215025, People's Republic of China; 3 Department of Pharmaceutical Sciences, College of Pharmacy, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48109, USA; 4 Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, People's Republic of China Correspondence: Dong Mei; Libo Zhao, Email ; Background: Nanomedicines have significant advantages in enhancing the oral bioavailability of drugs, but a deeper understanding of the underlying mechanisms remains to be interpreted. Hence, the present study aims to explain the uptake and trafficking mechanism for 6-MP nanomedicines we previously constructed. Methods: 6-MP loaded poly(lactide-co-glycolide) (PLGA) nanomedicines (6-MPNs) were prepared by the multiple emulsion method. The transcytosis mechanism of 6-MPNs was investigated in Caco-2 cells, Caco-2 monolayers, follicle associated epithelium (FAE) monolayers and rats, including transmembrane pathway, intracellular trafficking, paracellular transport and the involvement of transporter. Results: Pharmacokinetics in rats showed that the area under the curve (AUC) of 6-MP in the 6-MPNs group (147.3 ± 42.89 μg/L·h) was significantly higher than that in the 6-MP suspensions (6-MPCs) group (70.31 ± 18.24 μg/L·h). The uptake of 6-MPNs in Caco-2 cells was time-, concentration- and energy-dependent. The endocytosis of intact 6-MPNs was mediated mainly through caveolae/lipid raft, caveolin and micropinocytosis. The intracellular trafficking of 6-MPNs was affected by endoplasmic reticulum (ER)-Golgi complexes, late endosome-lysosome and microtubules. The multidrug resistance associated protein 4 (MRP4) transporter-mediated transport of free 6-MP played a vital role on the transmembrane of 6-MPNs. The trafficking of 6-MPNs from the apical (AP) side to the basolateral (BL) side in Caco-2 monolayers was obviously improved. Besides, 6-MPNs affected the distribution and expression of zona occludens-1 (ZO-1). The transport of 6-MPNs in FAE monolayers was concentration- and energy-dependent, while reaching saturation over time. 6-MPNs improved the absorption of the intestinal Peyer's patches (PPs) in rats. Conclusion: 6-MPNs improve the oral bioavailability through multiple pathways, including active transport, paracellular transport, lymphatic delivery and MRP4 transporter. The findings of current study may shed light on the cellular uptake and transcellular trafficking mechanism of oral nanomedicines. Keywords: nanomedicines, oral bioavailability, cellular uptake, transport mechanism 6-Mercaptopurine (6-MP) is one of the most commonly used drugs in clinical practice, which comprises the backbone of oral continuing therapy of childhood acute lymphocytic leukemia (ALL). 1 However, its low water solubility, short half-life, poor bioavailability and serious side effects have limited its clinical efficacy. 2 Thus, it is necessary to develop appropriate formulations to overcome these defects. In recent years, researchers have employed different effective methods to improve the delivery of 6-MP. 3–5 The application of nanotechniques in oral drug delivery shows unique advantages for increasing the bioavailability of poorly water-soluble drugs. In our previous study, we constructed the 6-MP loaded nanomedicines (6-MPNs) with poly(lactide-co-glycolide) (PLGA) through the modified double emulsion method. It has been confirmed that 6-MPNs enhanced the oral bioavailability of 6-MP because of its increased duodenal absorption. 6 Nevertheless, 6-MPNs need to overcome the intestinal epithelial cell barriers before being absorbed into the blood circulation. How nanomedicines promote transmembrane absorption and transport remains to be further studied. A recent study demonstrated that nanomedicines entered the cells through the following different pathways: (1) Traditional opinions suggested that the drugs in nanomedicines were transmitted via intestine barrier in the molecular form. 7 (2) Some other perspectives demonstrated that nanomedicines might alter the traditional absorption pathways of drugs. In particular, nanomedicines were able to trigger endocytosis, thereby enhancing the capability of drugs to cross the intestinal epithelial cell membrane. 8 (3) The microfold cell -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology